Study details
Enrolling now
Hyperpolarized 129Xe MR Imaging of Lung Function
Mario Castro, MD, MPH
NCT IDNCT04624490ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
260
Study length
about 6 years
Ages
3+
Locations
1 site in KS
What this study is about
Researchers are testing a new way to measure lung function using a gas called hyperpolarized xenon. The trial will involve healthy volunteers and people with various lung diseases like asthma, COPD, cystic fibrosis, and interstitial lung disease. It aims to see if this imaging technique can accurately assess how well the lungs are working.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Hyperpolarized Xe129
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
Diagnostic Agent (Imaging Contrast Activity)
Body systems
Infectious, Respiratory